Risk Intelligence
CCT integration and margin improvement timeline
View Risks →Fineotex Chemical delivered a strong Q3 FY26 with revenue surging 46% YoY to ₹190 crore, driven by the acquisition of Crude Chem Technology (CCT) and improving demand in textiles and oil & gas.
✓ Verified against BSE filing
Fineotex Chemical delivered a strong Q3 FY26 with revenue surging 46% YoY to ₹190 crore, driven by the acquisition of Crude Chem Technology (CCT) and improving demand in textiles and oil & gas. Export share jumped to 48% from 25% last quarter, reflecting successful international expansion. The company maintained a debt-free balance sheet with ₹340 crore cash and received ₹35.68 crore from warrant conversions. Management guided for ₹1,000 crore+ revenue in FY27, with oil & gas expected to contribute 45-50% of sales. Capacity utilization stands at 64%, with 39% volume growth YoY. Risks include integration challenges at CCT and potential margin pressure from textile pricing rollbacks.
CCT integration and margin improvement timeline
View Risks →Full transcript text is available on this route.
Read Transcript →Export share increased from 25% in Q2 FY26 to 48% in Q3 FY26, driven by CCT acquisition.
Overall volume growth including CCT; excludes standalone volume breakdown.
Overall capacity utilization across all plants; new Amber plant commissioned recently.
Crude Chem Technology's annual revenue run-rate of ~$65-66 million as per last records.
Management expects consolidated revenue to exceed ₹1,000 crore in the next financial year, driven by CCT full-year contribution and textile recovery.
CCT was consolidated for only 15 days in Q3; achieving double-digit margins may take longer than expected due to integration complexities.
View Risks →